ArticlePharmaceutics2019

Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations.

Muhammad F Rasool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.